[Treatment of Kaposi's disease].
Bachelez
H
H
Service de Dermatologie clinique et vénéréologie, Hôpital Henri Mondor, Créteil.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007370:Interferon Type I / Q000627:therapeutic use; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000209:etiology / Q000628:therapy*; D014983:Xeroderma Pigmentosum / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*
D000970:Antineoplastic Agents; D007370:Interferon Type I; D011994:Recombinant Proteins
Le traitement de la maladie de Kaposi.